- Home
- CSIQ vs AUTL Comparison
CSIQ vs AUTL Comparison
Compare CSIQ & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSIQ
- AUTL
- Stock Information
- Founded
- CSIQ 2001
- AUTL 2014
- Country
- CSIQ Canada
- AUTL United Kingdom
- Employees
- CSIQ N/A
- AUTL N/A
- Industry
- CSIQ Semiconductors
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CSIQ Technology
- AUTL Health Care
- Exchange
- CSIQ Nasdaq
- AUTL Nasdaq
- Market Cap
- CSIQ 837.1M
- AUTL 863.6M
- IPO Year
- CSIQ 2006
- AUTL 2018
- Fundamental
- Price
- CSIQ $11.93
- AUTL $2.44
- Analyst Decision
- CSIQ Hold
- AUTL Strong Buy
- Analyst Count
- CSIQ 11
- AUTL 3
- Target Price
- CSIQ $19.31
- AUTL $10.20
- AVG Volume (30 Days)
- CSIQ 2.0M
- AUTL 1.9M
- Earning Date
- CSIQ 12-05-2024
- AUTL 11-12-2024
- Dividend Yield
- CSIQ N/A
- AUTL N/A
- EPS Growth
- CSIQ N/A
- AUTL N/A
- EPS
- CSIQ N/A
- AUTL N/A
- Revenue
- CSIQ $6,174,205,000.00
- AUTL $10,091,000.00
- Revenue This Year
- CSIQ N/A
- AUTL $1,000.24
- Revenue Next Year
- CSIQ $17.24
- AUTL $267.86
- P/E Ratio
- CSIQ $985.50
- AUTL N/A
- Revenue Growth
- CSIQ N/A
- AUTL 82.71
- 52 Week Low
- CSIQ $10.91
- AUTL $2.44
- 52 Week High
- CSIQ $26.85
- AUTL $7.45
- Technical
- Relative Strength Index (RSI)
- CSIQ 45.76
- AUTL 30.41
- Support Level
- CSIQ $11.17
- AUTL $2.44
- Resistance Level
- CSIQ $13.20
- AUTL $2.97
- Average True Range (ATR)
- CSIQ 0.69
- AUTL 0.17
- MACD
- CSIQ 0.00
- AUTL -0.03
- Stochastic Oscillator
- CSIQ 29.30
- AUTL 4.57
About CSIQ Canadian Solar Inc. (ON)
Canadian Solar Inc is a Canadian solar power company. It is an integrated provider of solar power products, services, and system solutions. The company engages in designing, developing, and manufacturing solar ingots, wafers, cells, modules, and other solar power products. It operates through two business segments CSI Solar and Recurrent Energy segment. The CSI Solar segment designs, develops, and manufactures solar ingots, wafers, cells, modules, and other solar power and battery storage products. Its Recurrent segment primarily comprises solar and battery storage project development and sale, O&M and asset management services for operational projects, sale of electricity, and investment in retained assets.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.